Table 8.
Meas * | PC ** | # Rank | % *** | Meas | BC | Rank | % | Meas | OGC | Rank | % | Meas | LC | Rank | % | Meas | CC | Rank | % |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
9 | 64.2 | 1 | 1.00 | 10 | 62.3 | 1 | 1.00 | 9 | 67.7 | 1 | 1.00 | 10 | 78.7 | 1 | 1.00 | 32 | 70.0 | 1 | 1.00 |
10 | 64.2 | 1 | 0.97 | 14 | 57.1 | 2 | 0.94 | 10 | 64.5 | 2 | 0.97 | 14 | 76.0 | 2 | 0.97 | 4 | 66.0 | 2 | 0.97 |
35 | 62.3 | 3 | 0.94 | 30 | 57.1 | 2 | 0.94 | 4 | 58.1 | 3 | 0.94 | 13 | 73.3 | 3 | 0.94 | 10 | 64.0 | 3 | 0.85 |
16 | 60.4 | 4 | 0.88 | 17 | 56.1 | 4 | 0.91 | 14 | 54.8 | 4 | 0.91 | 11 | 69.3 | 4 | 0.91 | 14 | 64.0 | 3 | 0.85 |
17 | 60.4 | 4 | 0.88 | 12 | 55.5 | 5 | 0.88 | 12 | 51.6 | 5 | 0.88 | 32 | 68.0 | 5 | 0.88 | 31 | 64.0 | 3 | 0.85 |
20 | 30.2 | 31 | 0.12 | 23 | 33.7 | 31 | 0.12 | 29 | 32.3 | 27 | 0.12 | 20 | 33.3 | 31 | 0.09 | 1 | 34.0 | 31 | 0.09 |
23 | 28.3 | 32 | 0.06 | 1 | 32.5 | 32 | 0.06 | 21 | 29.0 | 32 | 0.09 | 22 | 33.3 | 31 | 0.09 | 2 | 34.0 | 31 | 0.09 |
24 | 28.3 | 32 | 0.06 | 20 | 32.5 | 32 | 0.06 | 27 | 25.8 | 33 | 0.06 | 2 | 32.0 | 33 | 0.06 | 20 | 32.0 | 33 | 0.03 |
3 | 26.4 | 34 | 0.03 | 21 | 32.2 | 34 | 0.03 | 1 | 22.6 | 34 | 0.00 | 27 | 30.7 | 34 | 0.03 | 22 | 32.0 | 33 | 0.03 |
21 | 24.5 | 35 | 0.00 | 22 | 31.3 | 35 | 0.00 | 23 | 22.6 | 34 | 0.00 | 1 | 22.7 | 35 | 0.00 | 21 | 30.0 | 35 | 0.00 |
* Measure, ** Prostate Cancer = PC, Breast Cancer = BC, Other Gastro Cancer = OGC, Lung Cancer = LC, Colon Cancer = CC, *** Percentage. Green spectrum = high priority, red spectrum = low priority. # In this table, the rank signifies the level of priority assigned to the corresponding measures, with green indicating the highest priority and red signifying the lowest priority among the measures in the participating countries. (Please refer to Table 2 for Measure names).